They started in Q3 of FY2021, and for that half year they made $6.3mUSD, at $50USD per month's supply = 126,000 scripts.
FY2022 = $8.3mUSD = 166,000 scripts.
FY2023 = $13.9m (forecast) = 278,000 scripts.
Japan could only give out a 2-week supply per script though, so that might change my numbers. I think Euroz Hartley's calculated a monthly cost of $50USD though. Need to check.
Following the September FDA CRL, EH advised:
BOT - Anything but charting, page-7517
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $636.1M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 36.0¢ | 34.0¢ | $2.246M | 6.430M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 54114 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 80800 | 5 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |